Conmed (CNMD) Debt to Equity (2010 - 2026)

Conmed has reported Debt to Equity for 17 years, with the latest figure at $0.85 in Q1 2026.

• For the quarter ending Q1 2026, Debt to Equity fell 7.3% year-over-year to $0.85; the trailing twelve-month figure through Mar 2026 stood at $0.85 (down 7.3% YoY), and the FY2025 full-year result was $0.81, down 14.1% from the prior year.
• Debt to Equity for Q1 2026 stood at $0.85, up from $0.81 in the prior quarter.
• The five-year high for Debt to Equity was $1.46 in Q2 2022, with the low at $0.81 in Q4 2025.
• Historically, Debt to Equity has averaged $1.11 across 5 years, with a median of $1.1 in 2024.
• Annual changes were most pronounced in 2022 — Debt to Equity soared 62.31% — and 2025, when it declined 21.28%.
• Conmed's Debt to Equity stood at $1.41 in 2022, then decreased by 17.49% to $1.17 in 2023, then dropped by 19.4% to $0.94 in 2024, then retreated by 14.1% to $0.81 in 2025, then gained by 4.67% to $0.85 in 2026.
• The last three Debt to Equity figures came in at $0.85 (Q1 2026), $0.81 (Q4 2025), and $0.85 (Q3 2025), per Business Quant data.